Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5786_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Contributors
- •Preface
- •1. Physics and instrumentation
- •Introduction
- •Sound
- •Short History of the Development of Ultrasound in Medicine
- •Near Field and Far Field
- •Focusing
- •Sound, Waves and Propagation
- •One Transducer for Each Purpose
- •The Ultrasound Beam
- •Resolution
- •Measurement
- •Time Gain Compensation
- •Artifacts
- •Edge Shadows
- •Attenuation Shadows
- •Enhancement
- •Reverberations
- •References
- •Further reading
- •2. Biological effects and safety aspects
- •Introduction
- •Acoustic Output of Diagnostic Ultrasound Scanners
- •Tissue Warming by Diagnostic Ultrasound
- •Non-Thermal Mechanisms and their Safety Implications
- •Gas Body Effects of Diagnostic Ultrasound
- •Other Mechanical Bioeffects Mechanisms
- •Evidence from Epidemiology
- •The Management of Safety
- •The Users' Responsibility
- •Thermal indices
- •Mechanical index
- •The Manufacturers' Obligations
- •Safety Practice
- •Diagnostic Ultrasound During the First Trimester
- •Scanning During the Second and Third Trimesters
- •Obstetric Scanning on Patients with Fever
- •Conclusion
- •References
- •3. Scanning techniques in obstetrics and gynaecology
- •Introduction
- •General Aspects
- •Empty or Full Bladder
- •Patient Information
- •The Examination Table
- •Bimanual Pelvic Examination Preceding the Scan
- •Equipment
- •Orientation
- •Scanning Routine
- •Obstetric Scanning
- •Biophysical profile
- •Gynaecological Scanning
- •The uterus
- •The cervix
- •The myometrium
- •The endometrium
- •Adnexal Masses
- •Peritoneal Fluid
- •Urinary Bladder
- •Other Findings
- •Colour Doppler Studies
- •Screening for Ovarian Masses
- •Transperineal and Transrectal Scanning
- •Ultrasound-Guided Puncture Procedures
- •Conclusion
- •References
- •4. Investigation of early pregnancy
- •Introduction
- •Description of the Sonoanatomic Development
- •Measurements of the Embryo/Early Fetus
- •Extraembryonic Structures: The Three Sacs
- •Multiple Pregnancy: Determination of Chorionicity and Amnionicity
- •Evaluation of Early Pregnancy Failure
- •Early Pregnancy Loss
- •Gestational sac (chorionic cavity) and amniotic cavity
- •Yolk sac
- •Haematoma
- •Heart rate
- •Trophoblastic Disease
- •Complete hydatidiform mole
- •Partial hydatidiform mole
- •Invasive hydatidiform mole
- •Choriocarcinoma
- •Ectopic Pregnancy
- •Early Anomalies
- •Standardization of Transvaginal and Transabdominal Imaging in Gynaecology
- •Imaging in Medicine
- •References
- •5. Normal fetal anatomy at 18–22 weeks
- •Introduction
- •Scan Guidelines
- •Normal Fetal Anatomy
- •Brain/Calvarium
- •Transthalamic view
- •Transventricular view
- •Heart
- •Transcerebellar view
- •Face and Neck
- •Spine
- •Lungs and Thorax
- •Abdomen
- •Anterior Abdominal Wall
- •Urinary Tract
- •Genitalia
- •Skeleton and Extremities
- •Conclusion
- •References
- •6. Amniotic fluid and placental localization
- •Amniotic Fluid
- •Amniotic Fluid Physiology
- •Fetal urinary production
- •Lung fluid
- •Flow across the chorionic plate
- •Amniotic Fluid Volume
- •Methods of assessment
- •Normal amniotic fluid volume values
- •Abnormal amniotic fluid volumes
- •Oligohydramnios
- •Polyhydramnios
- •Conclusions
- •Placenta Localization
- •Embryology
- •Functional anatomy
- •Development of the placenta as evaluated by ultrasound technology
- •Indications for the Location of the Placenta
- •Various locations of the placenta
- •Placenta praevia
- •Suggested management protocol for suspected placenta praevia
- •Placental Morphology
- •Conclusion
- •References
- •7. Assessment of the placenta and umbilical cord
- •Introduction
- •Major Structural Abnormalities of the Placenta
- •Congenital Abnormalities
- •Abnormalities of placentation
- •Placenta extrachorialis
- •Placenta accreta
- •Placental tumours
- •Mesenchymal tumours
- •Gestational trophoblastic tumours (GTD)
- •Secondary Abnormalities
- •Vascular abnormalities
- •Thrombosis and infarcts
- •Haematomas
- •Major Structural Abnormalities of the Umbilical Cord
- •Congenital Abnormalities
- •Abnormalities of the cord insertion
- •Single umbilical artery (SUA) syndrome
- •Cord tumours
- •Secondary Abnormalities
- •Vascular abnormalities
- •Haematomas and thrombosis
- •Vascular abnormalities
- •Abnormal cord position
- •References
- •8. Examining the cervix by transvaginal ultrasound
- •Introduction
- •Transvaginal Ultrasound of the Cervix Predicts Preterm Delivery
- •Measurement Technique
- •Transvaginal Ultrasound of the Cervix in the Clinical Judgement of Preterm Labour
- •Treatment of Cervical Incompetence
- •Prophylactic Cerclage or Transvaginal Follow-Up of the Cervix
- •Prophylactic Treatment with Progesterone in Pregnant Women with Short Cervix
- •Conclusion
- •References
- •9. Fetal biometry, estimation of gestational age, assessment of fetal growth
- •Principles of Fetal Biometry
- •Aims of Fetal Biometry
- •The Reference Values
- •Patient Selection and Study Design
- •Longitudinal and Cross-Sectional Studies
- •Sample Size
- •Displaying Data and Curve Fitting
- •Linear regression analysis
- •Curvilinear regression analysis
- •The coefficients of correlation
- •The F test
- •Prediction of Date and Size
- •The Confidence Limits
- •Dating
- •Menstrual, Conceptual and Gestational Age
- •Errors of Measurements
- •The Accuracy of Dating
- •Biometric Parameters
- •Gestational Sac
- •Crown–Rump Length
- •Head Measures
- •Abdominal Size
- •Limbs
- •Other Measurements and Dating
- •Data Report
- •Fetal Weight Estimation
- •Biometric Ratios
- •Other Parameters
- •Evaluation of Fetal Growth
- •Definition
- •Unsolved Problems
- •Screening and Diagnostic Strategies
- •Fetal Growth Restriction
- •Macrosomia
- •Fetal Biometry, Anomalies and Syndromes
- •Conclusion
- •References
- •10. Prenatal diagnosis of fetal anomalies
- •An Introduction to Congenital Anomalies
- •Central Nervous System Anomalies
- •Neural Tube Defects
- •Ventriculomegaly
- •Holoprosencephaly
- •Agenesis of the Corpus Callosum
- •Dandy–Walker Complex
- •Microcephaly
- •Destructive Cerebral Lesions
- •Choroid Plexus cysts
- •Craniofacial Anomalies
- •Facial Clefts
- •Ocular and Orbital Defects
- •Cardiac Anomalies
- •Atrial and Ventricular Septal Defects
- •Atrioventricular septal defects
- •Heterotaxy
- •Univentricular Heart
- •Aortic Stenosis
- •Coarctation, Tubular Hypoplasia and Interruption of the Aortic Arch
- •Hypoplastic Left Heart Syndrome
- •Pulmonary Stenosis and Pulmonary Atresia
- •Conotruncal Malformations
- •Ebstein's Anomaly and Tricuspid Valve Dysplasia
- •Echogenic Foci
- •Cardiac Dysrhythmias
- •Thoracic Anomalies
- •Hyperechogenic and Cystic Lungs
- •Pleural effusions
- •Diaphragmatic Hernia
- •Anomalies of the Abdominal Wall and Gastrointestinal Tract
- •Omphalocele
- •Gastroschisis
- •Body Stalk Anomaly
- •Bladder Exstrophy and Cloacal Exstrophy
- •Oesophageal Atresia
- •Duodenal Atresia
- •Intestinal Obstruction
- •Echogenic Bowel
- •Meconium Peritonitis
- •Abdominal Cysts
- •Anomalies of the Kidneys and Urinary Tract
- •Renal Agenesis
- •Cystic Kidneys
- •Urinary Tract Enlargement
- •Skeletal Anomalies
- •Fetal Tumours
- •Hydrops Fetalis
- •Chromosomal Defects
- •Ultrasound Findings with Chromosomal Aberrations
- •Individual Risk Assessment of Chromosomal Aberrations by the use of Midtrimester Ultrasound
- •Absent or hypoplastic nasal bone (<2.5 mm)
- •Nuchal oedema or fold more than 6mm
- •Hyperechogenic bowel
- •Short femur
- •Echogenic foci in the heart
- •Choroid plexus cysts
- •Mild hydronephrosis
- •Accuracy of Ultrasound in the Detection of Fetal Anomalies
- •Conclusion
- •Note
- •References
- •11. Evaluation of fetal and uteroplacental blood flow
- •Introduction
- •Uterine Artery Doppler
- •Umbilical Artery Doppler
- •Middle Cerebral Artery Doppler
- •MCA in Fetal Growth Restriction
- •MCA in Fetal Anaemia
- •Ductus Venosus
- •Umbilical Vein
- •Doppler in Twin Pregnancies
- •References
- •12. Invasive procedures in obstetrics
- •Introduction
- •Counselling
- •Training
- •The Procedures
- •Asepsis
- •Chorionic Villous Sampling
- •Chorionic villus sampling in multiple gestations
- •Safety
- •Amniocentesis
- •Safety
- •Amniocentesis in multiple gestations
- •Fetal Blood Sampling
- •Technique
- •Complications
- •Intrauterine Fetal Blood Transfusion
- •Complications
- •Fetal Shunts
- •Techniques
- •Complications
- •Delivery and shunt removal
- •Outcome
- •Diagnostic and Operative Fetoscopy
- •Pregnancy Reduction in Multifetal Pregnancies
- •Technique
- •Selective Fetocide for Fetal Abnormality
- •Conclusion
- •References
- •13. Multiple pregnancies
- •Introduction
- •First-Trimester Ultrasound
- •Pregnancy Dating
- •Number of Fetuses
- •Chorionicity and Amnionicity
- •Nuchal Translucency
- •Invasive Diagnostic Procedures
- •Growth Discrepancy and Fetal Monitoring
- •Malformations and Fetal Demise
- •Twin–Twin Transfusion Syndrome
- •Twin Reversed Arterial Perfusion
- •Monoamniotic Twins
- •Higher-Order Multiple Pregnancies
- •References
- •14. Three-dimensional and four-dimensional ultrasound application in prenatal diagnosis
- •Introduction
- •Volume Acquisition
- •Static 3D
- •Real-Time 3D or 4D Ultrasound
- •Spatial and Temporal Image Correlation
- •Volume Data Display
- •Single Plane of Choice, Multiplanar Orthogonal Planes or Multiple Tomographic Parallel Slices
- •Surface Mode Rendering
- •Maximum Mode Rendering
- •Minimum Mode Rendering
- •Inversion Mode Rendering
- •Glass Body Mode Rendering
- •Volume Calculation
- •Conclusion
- •References
- •15. Fetal movement patterns and behavioural states
- •Introduction
- •Methodology
- •The Emergence of Fetal Movement Patterns
- •Body Movements in Normal Pregnancy
- •Fetal Breathing in Normal Pregnancy
- •Normal Development of Fetal Behavioural States
- •Altered Brain or Muscular Development
- •Intrauterine Growth Retardation (IUGR)
- •Maternal Diabetes
- •Preterm Contractions and/or Rupture of Membranes
- •Drugs, Medication, Stress and Fetal Stimulation
- •Conclusion
- •References
- •16. Normal gynaecological anatomy (uterus, tubes, ovaries)
- •Introduction
- •Normal Ultrasound Morphology of the Cervix Uteri
- •Normal Ultrasound Morphology of the Uterus in Women of Fertile Age
- •Normal Ultrasound Morphology of the Ovaries in Women of Fertile Age
- •Normal Ultrasound Morphology of the Uterus and Ovaries in Postmenopausal Women
- •Normal Ultrasound Morphology of the Uterus and Ovaries in Menopausal Transition
- •Normal Uterine and Ovarian Vascularization as Assessed by Doppler Ultrasound Technique
- •The Tubes
- •The Pouch of Douglas
- •Hydrosonography
- •Hystero-Contrast Salpingosonography (HyCoSy)
- •Acknowledgements
- •References
- •17. Gynaecological pathology: the uterus
- •Introduction
- •Congenital Uterine Anomalies
- •Uterine Fibroids
- •Uterine Sarcoma
- •Adenomyosis
- •Endometrial Polyps
- •Endometrial Hyperplasia and Malignancy
- •Conclusion
- •References
- •18. Gynaecological pathology: tubes and ovaries
- •Ovaries
- •Benign and Malignant Ovarian Cysts: General Considerations
- •Tumour Size
- •Tumour Structure
- •Cyst Wall and Septal Wall Thickness
- •Echo-Dense Foci and Acoustic Shadowing
- •Echogenicity
- •Morphology Scoring Systems
- •Benign and Malignant Neoplasms of the Ovary
- •Dysfunctional ovarian cysts
- •Follicle cysts
- •Corpus luteum cysts
- •Thecalutein cysts
- •Endometriosis
- •Epithelial ovarian tumours
- •Serous ovarian tumours
- •Mucinous ovarian tumours
- •Fibromas and fibrothecomas
- •Germ cell tumours
- •Adnexal Torsion
- •Tubes
- •Non-Infectious Diseases of the Fallopian Tubes
- •Tubal pregnancy
- •Fallopian tube carcinoma
- •Hydrosalpinx
- •Infectious Diseases of the Fallopian Tubes
- •Note
- •References
- •19. Doppler ultrasonography in gynaecology
- •Introduction
- •Adnexal Masses
- •Other Pelvic Pathology
- •In Vitro Fertilization
- •References
- •20. Medico-legal implications of ultrasound imaging in obstetrics and gynaecology
- •Introduction
- •The Legal Process
- •The Trial Process
- •Reducing the Risk of Litigation
- •Never undertake a type of scan with which you are not entirely familiar (unless in a learning environment)
- •Record sample images (and be able to retrieve them)
- •Always act professionally and responsibly
- •Be aware of the common traps (and avoid them!)
- •If the scan is suboptimal, say so and explain why
- •Ensure the equipment is appropriate
- •Defending a Claim
- •Recording Images
- •Documentation
- •Conclusion
- •21. Ethics and patient information
- •Introduction
- •Ethics, Medical Ethics and Ethical Principles
- •The Principle of Beneficence
- •The Principle of Respect for Autonomy
- •The Interaction of Beneficence and Respect for Autonomy in Clinical Judgement and Practice
- •The Ethical Concept of the Fetus as a Patient
- •The viable fetal patient
- •The previable fetal patient
- •Clinical Topics
- •Competence and Referral in Ultrasound Examination
- •Routine Ultrasound Screening and Risk Assessment of Pregnant Women
- •Disclosure of Results of Ultrasound Examinations
- •Confidentiality of Findings
- •Conclusion
- •References
- •Test yourself – questions and answers
- •Chapter 2 Biological Effects and Safety Aspects
- •Chapter 4 Investigation of Early Pregnancy
- •Chapter 5 Normal Fetal Anatomy at 18–22 Weeks
- •Chapter 6 Amniotic Fluid and Placental Localization
- •Chapter 10 Prenatal Diagnosis of Fetal Anomalies
- •Chapter 12 Invasive Procedures in Obstetrics
- •Chapter 13 Multiple Pregnancies
- •Chapter 17 Gynaecological Pathology: The Uterus
- •Chapter 19 Doppler Ultrasonography in Gynaecology
- •Chapter 21 Ethics and Patient Information
- •Answers
- •Index

✩ ✩✩✩✩✩✩✩✩✩✩✩
Hyperechogenic bowel
This is found in about 0.5% of fetuses and is usually of no pathological significance. The commonest cause is intra-amniotic bleeding but occasionally it may
be a marker of cystic fibrosis or chromosomal defects. For isolated hyperechogenic bowel the risk for trisomy 21 may be seven times the background.
Short femur
If the femur is below the fifth centile and all other measurements are normal,
the baby is likely to be normal but rather short. Rarely this is a sign of dwarfism.
Occasionally it may be a marker of chromosomal defects. On the basis of existing studies, short femur is found four times as commonly in trisomy 21 fetuses
compared to normal fetuses. However, there is some evidence that isolated short
femur may not be more common in trisomic than normal fetuses.
Echogenic foci in the heart
These are found in about 4% of pregnancies and they are usually of no pathological significance. However, they are sometimes associated with cardiac defects and
Ultrasound in obstetrics and gynaecology
chromosomal abnormalities. For isolated hyperechogenic foci the risk for trisomy
21 may be three times the background.
Choroid plexus cysts
These are found in about 1–2% of pregnancies and they are usually of no pathological significance. When other defects are present there is a high risk of chromosomal defects, usually trisomy 18 but occasionally trisomy 21. For isolated choroid
plexus cysts the risk for trisomy 18 and trisomy 21 is 1.5 times the background.
204
Mild hydronephrosis
This is found in about 1–2% of pregnancies and is usually of no pathological significance. When other abnormalities are present there is a high risk of chromosomal defects, usually trisomy 21. For isolated mild hydronephrosis the risk for
trisomy 21 is 1.5 times the background.
ACCURACY OF ULTRASOUND IN THE DETECTION OF FETAL ANOMALIES
In the 1980s, there were great expectations that the systematic use of ultrasound
would allow recognition of most fetal anomalies. In most European countries, an
obstetric sonogram at midgestation rapidly became the standard of care. However,
the results of the available studies
variations (Table 10.3). The disappointing sensitivities of some studies were prob-
ably the consequence of inadequate expertise of the operators and it is reassuring to note a progressive improvement throughout the years. Most of the studies
published in the late 1990s described sensitivities in excess of 50%. A word of
caution is, however, necessary. Some of the series with the best results had an
unusually low prevalence of anomalies at birth, in the region of 1%. These low
18–27
demonstrate great national and regional

✩✩✩✩✩✩✩✩✩✩✩ ✩
Table 10.3 Studies documenting the results of routine obstetric ultrasound for the
detection of fetal anomalies
Study
Rosendahl 1989
Saari-Kemppainen
23
1990
Chitty 1991
Levi 1992 15,654 2.3 0.21 1.00 4
Shirley 1992
Luck 1992
Ewigmann 7617 2.46 0.17 − 4
Levi 1995
Boyd 1998
Whitlow 1999
19
26
22
21
18
27
Cases
25
9012 1.03 0.39 0.999 4
4691 0.43 0.47 0.998 2
8785 1.5 0.74 0.999 11
6412 1.4 0.60 0.999 8
8844 1.9 0.85 0.999 16
9392 2.45 0.41 0.999 9
33,376 2.17 0.55 0.995 11
6443 1.4 0.81 0.999 8
Prevalence of
anomalies at
birth (%)
Sensitivity
Specificity
Anomalies
detected
per 1000
pregnancies
figures may be the consequence of incomplete postnatal ascertainment, which of
course would lead to overestimation of the real sensitivity of antenatal studies.
At the time of writing, the accuracy of ultrasound in detecting fetal anomalies
remains a subject of debate in the literature. Fetal ultrasound is clearly the combination of sophisticated technology and skilled medical craftsmanship, strictly
intertwined. The ability to detect fetal anatomical defects depends largely upon
the operator's skills and expertise. It is clear that despite the quality of instrumentation and the ability of the operator, a reasonable proportion of fetal anomalies will be missed. The remarkable results of pilot studies performed in referral
centres are largely due to the selection of patients. Such studies include large
numbers of pregnancies in which either a fetal anomaly had been previously
suspected during a basic scan or there was a family history of anomalies amenable to ultrasound diagnosis. Independently from the expertise of the operator
or the equipment used, some fetal anomalies will not be detectable in utero or
in early gestation due to either late development or limitations of current ultrasound technology. Examples of the former group of lesions include persistence of
the fetal circulation, disruptions (porencephaly, migrational disorders), tumours,
intestinal obstructions, urinary tract dilation and many types of skeletal dysplasias. Examples of the latter group include ventricular and atrial septal defects.
Given the heterogeneity of congenital anomalies, in many cases it remains difficult to establish whether a specific condition can be recognized in early gestation
or not. Indeed, even within the same centre indicated sonograms result in a much
greater sensitivity than screening examination performed on low-risk patients.
28
One important problem that is surfacing and that needs to be addressed when
establishing a program of ultrasound screening in pregnancy is the issue of the
so-called soft markers. This term is commonly employed to define an ultrasound
Prenatal diagnosis of fetal anomalies
205

✩ ✩✩✩✩✩✩✩✩✩✩✩
finding that is not abnormal per se but increases the likelihood of a fetal anomaly,
most frequently a chromosomal aberration. An increased nuchal fold or a choroid plexus cyst represents a typical example. The surveys on the systematic use
of ultrasound in pregnant patients in the 1980s and early 1990s were at variance
in the sensitivity, but luckily specificity was invariably high in all studies, no matter the type of population scanned or the ultrasonographic expertise of those
performing the examinations. False positives occurred in less than 1 case in 1000
patients. It was reassuring to know that although anomalies could be missed, they
were very rarely overdiagnosed. While a false-negative diagnosis may leave the
family with the emotional, medical, social and economic burdens imposed by a
child born with a congenital anomaly, false-positive diagnoses may be ominous as
well since they may lead to termination of a normal fetus.
In one recent study, soft markers were responsible for a false-positive rate
greater than 1 in 200.18 Although it is debatable whether a soft marker should be
considered a false positive or more simply a risk factor for further investigation,
there is no doubt that they can cause a great deal of parental anxiety.
Ultrasound in obstetrics and gynaecology
The available experience on soft markers is conflicting. Different researchers have reported different results, many different markers have been described,
and some of them have subjective definitions (e.g. hyperechogenic bowel).
A review of the literature suggested that the use of soft markers in low-risk patients
allows detection of some fetal anomalies, but at the same time results in severe
anxiety for a number of couples and increases the number of invasive tests.
In the study previously quoted, soft markers increased the sensitivity of the midtrimester sonogram from 51% to 55% but at the same time they increased 12-fold
the false-positive rate, from 1 in 2332 to 1 in 188.18 At present there is a lack of
consensus on whether soft markers should be employed in low-risk patients, and
if so, which soft markers should be used and how the patients should be coun-
30
selled.
As this is likely to become one of the most critical issues in the future of
obstetric ultrasound, every ultrasound laboratory should establish its own policy.
The most important variables to consider in establishing such a policy include the
expectations of the population that is undergoing the ultrasound examination,
the experience of the operators, the availability of other screening programmes
such as nuchal translucency at 11–14 weeks’ scan and maternal biochemistry that
has been demonstrated to be more reproducible.
29
206
CONCLUSION
A careful ultrasound examination of the midtrimester fetus, performed with current
ultrasound technology by an expert examiner, allows the detection of many anomalies, probably in the range of 50% of those that can be identified at birth. The systematic use of a well-defined set of qualitative as well as quantitative parameters is
critical for the good result of the examination. Some areas of fetal anatomy remain
difficult to evaluate, the most remarkable example being the heart. It is expected
that advances in the technology of diagnostic ultrasound, better training and increasing awareness of the operators will further improve the current standards.

✩✩✩✩✩✩✩✩✩✩✩ ✩
Note
Further images relating to this chapter are found on the CD accompanying this
book.
References
Prenatal diagnosis of fetal anomalies
1. Romero R, Pilu G, Jeanty P, Ghidini A,
Hobbins JC. Prenatal diagnosis of congenital
anomalies. Appleton and Lange, Norwalk,
CT, 1988
2. Nyberg D, Mahony BS, Pretorius D.
Diagnostic ultrasound of fetal anomalies:
text and atlas. Year Book Medical Publishers,
Chicago, 1990
3. Pilu G, Nicolaides KH. Diagnosis of fetal
abnormalities. The 18–23 week scan.
Parthenon Publishing, London, 1999
4. Nyberg D, McGahan J, Pretorius D,
Pilu G. Diagnostic ultrasound of fetal
anomalies. Lippincott, Williams and Wilkins,
Philadelphia, 2001
5. Kalter H, Warkany J. Medical progress.
Congenital malformations: etiologic factors
and their role in prevention (first of two
parts). N Engl J Med 1983;308:24–31
6. Kalter H, Warkany J. Congenital
malformations (second of two parts).
N Engl J Med 1983;308:91–97
7. Leck I. Fetal malformations. In: Barron SL,
Thomson AM (eds) Obstetrical epidemiology.
Academic Press, London, 1983: 263–318
8. CDC. Achievements in public health,
1900–1999: healthier mothers and babies.
MMWR 1999;48(38):849–857
9. CDC. Contribution of birth defects to
infant mortality – United States, 1986.
MMWR 1989;38:633
10. Anderson RN, Kochanek KD, Murphy SL.
Report of the final mortality statistics, 1995.
US Department of Health and Human
Services, CDC, National Center for Health
Statistics, Hyattsville, MD, 1997
11. Ventura SJ, Martin JA, Curtin SC, Mathews
TJ. Report of final natality statistics, 1995.
US Department of Health and Human
Services, CDC, National Center for Health
Statistics, Hyattsville, MD, 1997
12. National Center for Health Statistics. Vital
statistics of the United States, 1968, vol II,
mortality, part A. US Department of Health,
Education and Welfare, Public Health
Service, CDC, Rockville, MD, 1972
13. Filly RA, Cardoza JD, Goldstein RB,
Barkovich AJ. Detection of fetal central
nervous system anomalies: a practical level
of effort for a routine sonogram. Radiology
1989;172(2):403–408
14. Copel JA, Pilu G, Green J, Hobbins JC,
Kleinman CS. Fetal echocardiographic
screening for congenital heart disease: the
importance of the four-chamber view. Am J
Obstet Gynecol 1987;157(3):648–655
15. Buskens E, Grobbee DE, Frohn-Mulder
IM et al. Efficacy of routine fetal
ultrasound screening for congenital heart
disease in normal pregnancy. Circulation
1996;94(1):67–72
16. Tegnander E, Williams W, Johansen OJ,
Blaas HJ, Eik-Nes SH. Prenatal detection of
heart defects in a non-selected population
of 30,149 fetuses – detection rates and
outcome. Ultrasound Obstet Gynecol
2006;27:252–265
17. Allan L, Benacerraf B, Copel JA
et al. Isolated major congenital heart
disease. Ultrasound Obstet Gynecol
2001;17(5):370–379
18. Boyd PA, Chamberlain P, Hicks NR.
6-year experience of prenatal diagnosis in
an unselected population in Oxford, UK.
Lancet 1998;352(9140):1577–1581
19. Chitty LS, Hunt GH, Moore J, Lobb MO.
Effectiveness of routine ultrasonography
in detecting fetal structural abnormalities
in a low risk population. BMJ
1991;303(6811):1165–1169
20. Levi S, Hyjazi Y, Schaaps JP, Deffoort P,
Coulon R, Bueckens P. Sensitivity and
specificity of routine antenatal screening
for congenital anomalies by ultrasound:
the Belgian Multicentric Study. Ultrasound
Obstet Gynecol 1991;1(2):102–110
21. Levi S, Schaaps JP, De Havay P, Coulon R,
Defoort P. End-result of routine ultrasound
screening for congenital anomalies: the
Belgian Multicentric Study 1984–92.
Ultrasound Obstet Gynecol 1995;5(6):
366–371
22. Luck CA. Value of routine ultrasound
scanning at 19 weeks: a four year
study of 8849 deliveries. BMJ
1992;304(6840):1474–1478
23. Saari-Kemppainen A, Karjalainen O,
Ylostalo P, Heinonen OP. Ultrasound
screening and perinatal mortality: controlled
trial of systematic one-stage screening in
pregnancy. The Helsinki Ultrasound Trial.
Lancet 1990;336(8712):387–391
207

✩ ✩✩✩✩✩✩✩✩✩✩✩
24. Saari-Kemppainen A, Karjalainen O,
Ylostalo P, Heinonen OP. Fetal anomalies in
a controlled one-stage ultrasound screening
trial. A report from the Helsinki Ultrasound
Trial. J Perinat Med 1994;22(4):279–289
25. Rosendahl H, Kivenen S. Antenatal
detection of congenital malformations by
routine ultrasonography. Obstet Gynecol
1989;73(6):947–951
26. Shirley IM, Bottomley F, Robinson VP.
Routine radiographer screening for
fetal abnormalities by ultrasound in an
unselected low risk population. Br J Radiol
1992;65(775):564–569
27. Whitlow BJ, Chatzipapas IK, Lazanakis ML,
Kadir RA, Economides DL. The value
of sonography in early pregnancy for
the detection of fetal abnormalities in
an unselected population. Br J Obstet
Gynaecol 1999;106(9):929–936
28. Van Dorsten JP, Hulsey TC, Newman RB,
Ultrasound in obstetrics and gynaecology
Menard MK. Fetal anomaly detection
by second-trimester ultrasonography in
a tertiary center. Am J Obstet Gynecol
1998;178(4):742–749
29. Smith-Bindman R, Hosmer W, Feldstein
VA, Deeks JJ, Goldberg JD. Secondtrimester ultrasound to detect fetuses with
Down syndrome: a meta-analysis. JAMA
2001;285(8):1044–1055
30. MacLachlan N, Iskaros J, Chitty L. Ultrasound
markers of fetal chromosomal abnormality:
a survey of policies and practices in UK
maternity ultrasound departments. Ultrasound
Obstet Gynecol 2000;15(5):387–390
31. Whitby EH, Paley MN, Sprigg A et al.
Comparison of ultrasound and magnetic
resonance imaging in 100 singleton
pregnancies with suspected brain
abnormalities. Br J Obstet Gynaecol
2004;111:784–792
32. Von Koch CS, Glenn OA, Goldstein RB,
Barkorich AJ. Fetal magnetic resonance
imaging enhances detection of spinal cord
anomalies in patients with sonographically
detected bony anomalies of the spine.
J Ultrasound Med 2005;24:781–789
33. Goldstein I, Copel JA, Makhoul IR. Mild
cerebral ventriculomegaly in foetuses:
characteristicts and outcome. Fetal Diagn
Ther 2005;20:281–284
34. Gaglioti P, Danelon D, Bontempo S et al.
Fetal cerebral ventriculomegaly: outcome
in 176 cases. Ultrasound Obstet Gynecol
2005;25:372–377
35. Bernier FP, Crawford SG, Dewey D.
Developmental outcome of children
who had choroid plexus cysts detected
prenatally. Prenat Diagn 2005;25:322–326
36. Pajkrt E, Weisz B, Firth HV, Chitty LS. Fetal
cardiac anomalies and genetic syndromes.
Prenat Diagn 2004;24:1104–1115
37. Allan L, Benacerraf B, Cope L JA
et al. Isolated major congenital heart
disease. Ultrasound Obstet Gynecol
2001;17:370–379
38. Mohan UR, Kleinman CS, Kern JH. Fetal
echocardiography and its evolving impact
1992 to 2002. Am J Cardiol 2005;96:
134–136
39. Sharland G. Routine fetal cardiac screening:
what are we doing and what should we do?
Prenal Diagn 2004;24:1123–1129
40. Goncalves LF, Lee W, Chaiworaponga T
et al. Four-dimensional ultrasonography
of the fetal heart with spatiotemporal
image correlation. Am J Obstet Gynecol
2003;189:1792–1802
41. Wiesel A, Queisser-Luft A, Clementi M,
Bianca S, Stoll C, Euroscan Study Group.
Prenatal detection of congenital renal
malformations by fetal ultrasonographic
examination: an analysis of 709,030 births
in 12 European countries. Eur J Med Gen
2005;48:131–144
42. Damen-Elias HA, De Jong TP, Stigter RH,
Visser GH, Stoutenback PH. Congenital
renal tract anomalies: outcome and follow
up of 402 cases detected antenatal between
1986 and 2001. Ultrasound Obstet Gynecol
2005;25:134–143
43. Van Eijk L, Cohen-Overbeek TE, den
Hollander NS, Nijman JM, Wladimiroff JW.
Unilateral multicystic kidney: a combined
pre- and postnatal assessment ultrasound.
Obstet Gynecol 2002;19:180–183
44. Cohen-Overbeek TE, Wijngaard-Boom P,
Ursem NT, Hop WC, Wladimiroff JM,
Wolffenbuttel KP. Mild renal pyelectasis in
the second trimester: determination of cutoff levels for postnatal referral ultrasound.
Obstet Gynecol 2005;25:375–383
208

11
✩✩✩✩✩✩✩✩✩✩✩✩✩✩✩✩✩✩✩✩ ✩
Evaluation of fetal and uteroplacental blood flow
Annegret Geipel Ulrich Gembruch
ABSTRACT
Doppler application in modern obstetric practice has been expanded widely. Flow
velocity waveforms of maternal and fetal vessels provide important diagnostic
and prognostic information with respect to a variety of pregnancy complications.
Impaired placentation, as depicted by uterine Doppler sonography, is associated
with an increased risk for the development of pre-eclampsia and/or growth
restriction. Doppler information of fetal systemic vessels helps the obstetrician in
managing pregnancies complicated by intrauterine growth restriction. Longitudinal
observations of fetal Doppler changes in growth-restricted fetuses demonstrate
progressive deterioration of umbilical artery blood flow, followed by middle
cerebral artery velocimetry and finally ductus venosus blood flow. Doppler signal
characteristics aid in the decision on when to time the delivery. Further, the rate and
degree of deteriorating Doppler signals are closely related to the risks for adverse
perinatal outcome. The Doppler assessment of middle cerebral artery peak systolic
velocity is increasingly used in the surveillance of fetuses at risk for anaemia, thus
avoiding the need for invasive procedures. Doppler is also an invaluable contributor
in managing pregnancies complicated by heart disease or twin–twin transfusion
syndrome.
KEYWORDS
Ductus venosus, fetal anaemia, fetal Doppler, fetal growth restriction, middle
cerebral artery, pre-eclampsia, twin–twin transfusion syndrome, umbilical artery,
uteroplacental blood flow, venous Doppler.
INTRODUCTION
Doppler ultrasound assessment of the placental and fetal circulations plays an
important role in modern antenatal care. Uterine Doppler investigation is a
209

✩ ✩✩✩✩✩✩✩✩✩✩✩
screening tool for impaired placentation and its complications of pre-eclampsia,
fetal growth restriction and placental abruption. Doppler ultrasonography of fetal
vessels (umbilical artery, middle cerebral artery, ductus venosus) helps in the diagnosis and management of a wide range of pathological conditions, such as fetal
growth restriction (FGR), fetal anaemia, twin–twin transfusion syndrome (TTTS)
and fetal cardiac disease. Table 11.1 summarizes important topics of Doppler
application in pregnancy. As illustrated there, fetomaternal Doppler evaluation
is part of first- and second-trimester screening programmes in low- and highrisk pregnancies, the latter defined by history and by diagnosis of anatomical or
growth abnormalities in these examinations.
In clinical practice, arterial flow velocity waveforms are quantified by the use
of indices. The advantage of indices compared to absolute velocities is that they
Table 11.1 Indications for Doppler application in pregnancy
Ultrasound in obstetrics and gynaecology
Indication Gestational age Vessel Parameter
Detailed first trimester
screening
– advanced maternal age
– increased nuchal
translucency
History of
– pre-eclampsia/PIH/
placental abruption
– IUFD/ severe FGR
Maternal vascular disease
– lupus erythematodes/
antiphospholipid/
antibodies/thrombophilia
– hypertension
– diabetes mellitus
Abnormal fetal growth
– small for dates/FGR
– proved FGR
Risk of fetal anaemia
– red cell alloimmunization
– parvovirus infection
Twin pregnancy
– discordant growth
– TTTS/TRAP sequence
Fetal abnormality
– cardiac disease/
arrhythmia
– fetal hydrops
12–14 weeks DV a-wave (positive/
18–22 weeks uterine artery notching, PI/RI
18–22 weeks uterine artery notching, PI/RI
2nd/3rd trimester uterine artery
UA (1st), MCA (2nd)
UA, MCA, DV
2nd/3rd trimester MCA PSV
2nd/3rd trimester uterine artery
UA (1st), MCA (2nd)
UA, MCA, DV
2nd/3rd trimester UA, MCA, DV
fetal echocardiography
negative)
notching, PI/RI
PI/RI
PI/RI, PVIV/PIV
notching, PI/RI
PI/RI
PI/RI, MCA PSV,
PVIV/PIV
PI/RI, MCA PSV,
PVIV/PIV
210
DV, ductus venosus; FGR, fetal growth restriction; IUFD, intrauterine fetal death; MCA, middle cerebral
artery; PIH, pregnancy-induced hypertension, PI, pulsatility index; PIV, pulsatility index for veins; PSV,
peak systolic velocity, PVIV, peak velocity index for veins, RI, resistance index; TRAP, twin reversed
arterial perfusion; TTTS, twin–twin transfusion syndrome; UA, umbilical artery.

✩✩✩✩✩✩✩✩✩✩✩ ✩
Pulsatility Index (PI)
PI =
A Arterial Doppler (umbilical artery)
S −D
T
AMX
PI = = 1.2
30 −9
17
Resistance Index (RI)
RI =
S −D
S
RI = = 0.7
30 −9
30
Systolic/ Diastolic Ratio
S/ D Ratio =
S
D
S/ D =
30
9
= 3.3
Peak Velocity Index for Veins (PVIV)
Pulsatility Index for Veins (PIV)
PVIV = PVIV =
S −A
D
= 0.49
65 −34
63
PIV = PIV =
S −A
T
AMX
= 0.59
65 −34
52
B Venous Doppler (ductus venosus)
are angle independent. For the assessment of true velocities, an angle of insonation
close to 0 ° is desired, as otherwise with increasing angle the blood velocity is
progressively underestimated or increasingly incorrect if the function of angle
correction is used. Commonly used downstream indices that represent mainly
the impedance of the distal vascular bed are:
pulsatility index (PI)
•
resistance index (RI)
•
S/D ratio.
•
The calculation of these indices is demonstrated in Figure 11.1. The use of the
PI has the advantage of a wider spectrum of values in cases with no end-diastolic
flow component. In addition to the various indices, blood flow can be categorized
according to a particular waveform pattern, such as the presence or absence of an
end-diastolic component or of an end-diastolic notch. In general, a low-pulsatility
waveform represents a low distal resistance (e.g. normal uterine artery Doppler) and
Evaluation of fetal and uteroplacental blood flow
Figure 11.1 Calculation of commonly used Doppler indices. (A) Arterial Doppler (umbilical
artery). (B) Venous Doppler (ductus venosus).
211

✩ ✩✩✩✩✩✩✩✩✩✩✩
a high-pulsatility waveform indicates high peripheral resistance (e.g. normal middle
cerebral Doppler). Impedance to flow of the ductus venosus, the venae cavae or the
hepatic veins can be calculated by the following indices (see Fig. 11.1):
pulsatility index for veins (PIV)
•
peak velocity index for veins (PVIV).
•
UTERINE ARTERY DOPPLER
The impedance to flow in the uterine arteries decreases with advancing gestation
in normal pregnancies, reflecting the trophoblastic invasion of the spiral arteries. This process is complete by about 18 weeks' gestation. In pregnancies with
impaired placentation, high uterine vascular resistance will persist after this time
(Fig. 11.2). Uterine Doppler screening is commonly performed around 20 weeks
of gestation, as a part of the fetal anomaly scan.39 A transabdominal or transvaginal approach is possible. Colour Doppler assists in the quick visualization of the
uterine artery at its crossing with the external iliac artery. Pulsed-wave Doppler
Ultrasound in obstetrics and gynaecology
is used to obtain 3–5 similar consecutive waveforms from both sides. The waveform can be analysed by calculating indices (PI, RI) or by assessing the presence
or absence of an end-diastolic notch. Impedance of the uterine artery on the
placental side is usually lower. In most studies, the mean indices from both ves-
212
sels are calculated. Cut-off values at 23 weeks' gestation are a mean PI above
1.5–1.6
notches after 24 weeks' gestation also represents high uterine resistance and is
considered abnormal. Bilateral notches are found in about 25–30% of pregnancies
at 12 weeks, 10–15% at 20 weeks and 5% at 24 weeks. Notch quantification has
been suggested, but is rarely used in daily clinical practice. In the case of a laterally located placenta, blood flow on the placental side is more important. While
a notch on the non-placental side is of reduced significance, the presence of an
ipsilateral notch is of high importance.
fusion have demonstrated that high impedance to flow in the second trimester is
associated with a higher risk of pre-eclampsia, FGR or placental abruption. The
optimum gestational age for uterine screening studies is considered to be 20–
24 weeks of gestation, providing the best sensitivity/specificity trade-off. Increased
impedance to flow in the uterine arteries will identify about 40–50% of the pregnancies that will subsequently develop pre-eclampsia and approximately 30% of
those that will develop FGR. More importantly, abnormal uterine Doppler waveforms perform better in predicting severe, early-onset complications. The sensitivity of uterine Doppler screening for pre-eclampsia and FGR requiring delivery
before 34 weeks' gestation is about 80% and 60–70%, respectively (Table 11.2).
Another important finding of those studies is the high negative predictive value
of 98–99% for pre-eclampsia and 93–95% for FGR. This finding might aid in
stratifying a more risk-orientated antenatal care approach. Women with normal
uterine Doppler findings are unlikely to develop early pre-eclampsia or FGR and
1,38
or a mean RI above 0.57–0.58.
Over the last 25 years a number of Doppler studies on the uteroplacental per-
17,28
The persistence of bilateral

✩✩✩✩✩✩✩✩✩✩✩ ✩
Evaluation of fetal and uteroplacental blood flow
Figure 11.2 Uterine artery Doppler. (A) Normal impedance to flow at 22 weeks' gestation.
(B) Increased impedance to flow with end-diastolic notching at 24 weeks.
213
Соседние файлы в папке Библиотека им академика М.И. Перельмана
